Use cautionDrug recall · FDA · Published December 17, 2020
Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk
Fresenius Kabi recalls Ketorol: 60mg/2mL injection vials due to particulate matter found in reserve samples. This may cause serious injury if injected.
“Fresenius Kabi Ketorolac Injection Recall: Particulate Matter Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36591-fresenius-kabi-ketorolac-injection-recall-particulate-matter-risk. Based on FDA recall #D-0184-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0184-2021%22&limit=1).
Fresenius Kabi USA, LLC voluntarily recalled Ketorolac Tromethamine Injection USP due to the presence of particulate matter in reserve sample vials, according to the FDA. The Food and Drug Administration announced the Class II recall on December 17, 2020.
How to tell if you have it
Brand: Fresen: Kabi
Product: Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), packaged in 2 mL Single Dose Vial, Rx only
NDC: 63323-162-02
Batch #: 6121125
Expiration: 02/2021
The hazard
The recall addresses the presence of particulate matter found in reserve sample vials at the firm, according to the FDA.
Context
GovInfoNow's records show Fresenius Kabi USA, LLC has 65 other recalls on record since September 27, 2012. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (August 10, 2026), Fresen: Morphine Syringes May Have Wrong Labeling (August 4, 2026), and Fresenius Kabi Xylocaine 1% Injection Recall (July 16, 2026).
How to tell if you have this one
Check for vials labeled 'Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL)' from Fresenius Kabi. The NDC code 63323-162-02 and batch number 6121125 are associated with this recall.
Brand
Fresen: Kabi
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for the product name and NDC code on the vial to confirm it matches the recalled items.
Contact Healthcare Provider
If you have the recalled vial, inform your healthcare provider immediately to discuss next steps.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0184-2021 (December 17, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0184-2021 to see it in context.
Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.